Phase 3 Study to Evaluate Anecortave Acetate vs. Visudyne for the Treatment of the Wet Form of AMD
NCT00041483
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
530
Enrollment
INDUSTRY
Sponsor class
Conditions
Macular Degeneration
Interventions
DRUG:
Anecortave Acetate 15 mg sterile suspension
OTHER:
Photodynamic Therapy (PDT)
Sponsor
Alcon Research